Novel Molecular Subtyping Predicts Locoregional Recurrence in Triple-negative Breast Cancer
This study demonstrated that the BLIS subtype appears to be at a higher risk of developing LRR, and IHC-based molecular subtyping might be used as prognostic biomarkers to guide postmastectomy radiation therapy in patients with TNBC. New strategies that improve locoregional control rates in patients with BLIS are warranted.
Authors
- Zhaozhi Yang (ORCID: https://orcid.org/0000-0002-8127-8236)
- Xiaoli Yu
- Shali Shao
- Zhen Zhang (ORCID: https://orcid.org/0000-0001-7825-2679)
- Li Zhang (ORCID: https://orcid.org/0000-0002-6672-4808)
- Xiaomao Guo (ORCID: https://orcid.org/0000-0002-8700-982X)
- Qixian Zhang (ORCID: https://orcid.org/0000-0003-3534-8579)
- Jin Meng
- Miao Mo (ORCID: https://orcid.org/0009-0008-3842-1042)
- Wei Shi (ORCID: https://orcid.org/0009-0004-5305-4130)
Institutions
- Shanghai Medical College of Fudan University (CN)
- Fudan University Shanghai Cancer Center (CN)
- Women's Hospital, School of Medicine, Zhejiang University (CN)
- Shanghai Institute of Hematology (CN)
- Shanghai Clinical Research Center (CN)
Publication Details
- Journal
- Advances in Radiation Oncology
- Published
- 2025-10-04
- DOI
- https://doi.org/10.1016/j.adro.2025.101909
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00